PubMed HealthSearch

Biomedical subjects

A Schmelz

Publications and source records attributed to A Schmelz.

3 recordsLinked to original sources

Atherosclerosis in the aorta of hypercholesterolemic rabbits and the influence of daltroban.

These studies have examined aortic atherogenesis in cholesterol-fed rabbits and have correlated the effects of daltroban to the pathomechanism of the vessel wall lesions. After feeding a 0.5% cholesterol-enriched diet for 96 d atherosclerotic alterations were seen, which exhibited a proximo-distal pattern, to which the branching of the aorta contributed considerably. Depending on their localization and size a varying cellular constitution of the plaques was obvious. Large plaques, which were mainly seen in the aortic arch and the proximal descending thoracic aorta, consisted of numerous proliferating cells, masses of fibrillar ground substance, clusters of foam cells, and rarely contained cholesterol crystals and necroses. Emerging plaques mainly found in distal thoracic and abdominal aorta imposed as fatty streaks. Daltroban treatment, used in a clinically relevant doses of 10 mg/kg b. wt. per day, reduced extension and protrusional area of plaques to about 40%, which was evaluated using a newly developed computerized morphormetric method, in association with significant reductions in free cholesterol content within the aorta. The results suggest that daltroban inhibits the progression of atherosclerosis in cholesterol-fed rabbits. This effect may be related to its antagonistic interaction with the thromboxane A2 receptor and also to an inhibition of the cholesterol metabolism.

Animals

Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban.

In the pathogenesis of atherosclerosis an accumulation of lipids, predominantly in the form of cholesteryl esters within the blood vessel wall is observed. Interaction of the plaques, e.g. with platelets, is suggested to contribute considerably to their growth. Compounds affecting both processes should prevent atherosclerotic progression and therefore are of great interest for potential therapeutic use. We investigated the effect of Daltroban, which has been characterized as a selective thromboxane receptor antagonist with platelet inhibiting activity, in two models: 1) cholesterol metabolism in liver cells and 2) progression of atherosclerosis in aorta of hypercholesterolemic rabbits. Daltroban reduced 14C-acetate incorporation into cholesteryl esters stronger than into cholesterol in rat hepatocyte monolayer cultures. In male white New Zealand rabbits fed 0.5% cholesterol enriched diet for 96 days, coadministration of Daltroban beginning at the 42th day on diet reduced aortic cholesterol content, plaque covered surface of aortic wall, and lumen stenosis by plaques more than 30 percent. The significant inhibition of the progression of atherosclerosis in the hypercholesterolemic rabbits by Daltroban is suggested to be effected by both inhibition of cholesterol metabolism as well as of platelets.

Animals

[Morphologic studies for quantifying arteriosclerosis].

After application of a semisynthetic diet enriched with 0.5% cholesterol, hypercholesterolemia was produced in nine New Zealand rabbits. After 92 days the aortas were divided into 10 segments and analyzed using morphological methods. We used a computer-assisted morphometric method that was developed for measuring arteriosclerotic lesions of the vessel wall (length and area of plaques) within single aortic segments. We observed a proximo-distal segmental pattern of arteriosclerotic lesions of the aortic wall. The highest extent of atherosclerosis was found in the aortic arch, decreasing in extent in thoracal and abdominal regions. Our results show that segmental measurements of the aorta are necessary to analyze the extent of atherosclerosis reproducibly.

Age Factors